UBS Group »

Drugs Made In Amer Acqutn shares owned by UBS Group

Quarter-by-quarter ownership of Drugs Made In Amer Acqutn (DMAAR) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Drugs Made In Amer Acqutn

Tip: Access up to 7 years of quarterly data

All positions including Drugs Made In Amer Acqutn held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Drugs Made In Amer Acqutn by UBS Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $33 150 0.22

More positions owned by UBS Group

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Ubs Group SHS (UBS)
Tesla Motors (TSLA)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A (V)

View all positions for UBS Group

Top funds holding Drugs Made In Amer Acqutn

Polar Securities
Hudson Bay Capital Management
Harraden Circle Investments
Toronto-Dominion Bank
Highbridge Capital Management
Aristeia Capital
Mangrove Partners
Linden Advisors
Clear Street
Glazer Capital
Shaolin Capital Management
Atw Spac Management
Boothbay Fund Management
Wolverine Asset Management
LMR Partners

View all funds holding Drugs Made In Amer Acqutn